Guardia Clausi, Mariano

Intranasal administration of aTf protects and repairs the neonatal white matter after a cerebral hypoxic-ischemic event. [electronic resource] - Glia Oct 2012 - 1540-54 p. digital

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

1098-1136

10.1002/glia.22374 doi


2',3'-Cyclic Nucleotide 3'-Phosphodiesterase--genetics
Administration, Intranasal
Age Factors
Animals
Animals, Newborn
Antigens--metabolism
Apoproteins--administration & dosage
Autophagy-Related Proteins
Brain Injuries--etiology
Bromodeoxyuridine--metabolism
Caspase 3--metabolism
Cell Death--drug effects
Cell Proliferation--drug effects
Cells, Cultured
Cerebral Cortex--cytology
Colchicine--pharmacology
Corpus Callosum--drug effects
Cytochalasin B--pharmacology
Female
Gene Expression Regulation--drug effects
Green Fluorescent Proteins--genetics
Humans
Hypoxia--drug therapy
Hypoxia-Ischemia, Brain--complications
Intermediate Filament Proteins--metabolism
Intracellular Signaling Peptides and Proteins--metabolism
Lateral Ventricles--drug effects
Male
Mice
Mice, Transgenic
Myelin Basic Protein--metabolism
Nerve Fibers, Myelinated--drug effects
Nerve Tissue Proteins--metabolism
Nestin
Neurogenesis--drug effects
Neuroprotective Agents--administration & dosage
Oligodendroglia--drug effects
Platelet-Derived Growth Factor--metabolism
Proteoglycans--metabolism
SOXB1 Transcription Factors--metabolism
Time Factors
Transferrin--administration & dosage